(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DIA Global Center

Oct 15, 2018 8:15 AM - Oct 16, 2018 3:30 PM

21 Dupont Circle NW, Suite 300, Washington, DC 20036

Navigating Chemistry, Manufacturing, and Controls Through the Drug Development Process

Back to Agenda

Welcome, Introduction, and Session 1: Introduction/Overview of FDA

Session Chair(s)

Albert S. Yehaskel, MBA

Albert S. Yehaskel, MBA

President and CEO

Refuah Global Pharmaceutical Development, Inc., United States

  • FDA’s mission and how FDA is organized
  • CDER/CBER/CDRH role and responsibility
  • Critical role of FDA reviewer and chemistry reviewer
  • Responsibility of sponsor
  • What is CM&C
  • FDAs concerns with CM&C
  • Laws, regulations, policies and procedures

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.